Source: Stock Guru

RxS: RxS expands sample management reporting suite

MANALAPAN, NJ, Nov. 07, 2017 (GLOBE NEWSWIRE) - RxS LLC ("RxS"), a privately held company providing multi-channel sample management solutions to pharmaceutical and biotech companies, today announced the introduction of its proprietary "Compliance Report Card" as part of the continued expansion of the company's LinkedRx Suite of Reports and Dashboards. This new report simplifies the end-user experience in finding key data and information regarding a pharmaceutical sales representative's PDMA based transactions through a consolidated trending report. Information contained in this single report includes all compliance related transactions, sample management help desk correspondences, and trending views of the representative's reconciliations, audits [...]

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Mark Jara's photo - Co-Founder of RxS

Co-Founder

Mark Jara

CEO Approval Rating

81/100

Read more